Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Zylox-Tonbridge was Added to the FTSE Global Equity Index Series 2023-09-18 14:51
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance 2023-09-18 07:57
The "Jiangsu-Germany Dialogue 2023" Held in Changzhou 2023-09-15 16:38
Cure Genetics and Frametact Reach a $60 Million Collaboration and Licensing Agreement for the Development of Gene Therapy for Familial Neurological Diseases 2023-09-14 23:00
Porton Advanced and BRL Medicine Build Strategic Partnership to Accelerate Commercialization of Gene and Cell Therapies 2023-09-14 20:00
Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease 2023-09-14 20:00
Fujitsu and Baptist Health South Florida transform operating room scheduling with newly launched solution to boost utilization rates and the financial health of the surgical discipline 2023-09-14 18:03
Dizal Announces China CDE Acceptance of New Drug Application for Golidocitinib for Relapsed or Refractory PTCL 2023-09-14 17:07
Asieris' New Drug APL-1401 Completes First Administration in Patient with Moderately to Severely Active UC 2023-09-14 16:54
Nona Biosciences Expands Antibody Discovery Collaboration with BeiGene 2023-09-14 16:00
S-Patch Ex, Wearable ECG Patch, Cleared by US FDA 2023-09-13 21:00
Health In Tech's eDIYBS Takes Center Stage at SIIA 2023-09-13 20:30
Asieris Announces Positive Interim Analysis Results in Phase II Clinical Trial of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer 2023-09-13 19:09
Singleron launches AccuraCode® TCR library construction kit, enhancing efficiency and cost-effectiveness of high-throughput T-cell receptor profiling 2023-09-13 17:51
J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI 2023-09-13 15:58
Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China 2023-09-13 14:24
Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum's Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7 2023-09-13 13:42
AIRS Medical Inc. receives MDSAP Certification, Paving the Way for Global Expansion 2023-09-13 12:44
GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC. 2023-09-13 00:00
Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech 2023-09-12 22:00
1 75 76 77 78 79 800